TickerFactsScreenerDevelopers

Cartesian Therapeutics, Inc. (RNAC) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2014: $227.0K2015: $1.16M2016: $586.0K2017: $733.0K2018: $884.0K2019: $47.0K2020: $815.0K2021: $1.08M2022: $1.20M2023: $206.0K2024: $9.09M2025: $5.45M$5.45M
2014Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$5.45M-40.0%
2024$9.09M+4314.1%
2023$206.0K-82.8%
2022$1.20M+10.7%
2021$1.08M+33.1%
2020$815.0K+1634.0%
2019$47.0K-94.7%
2018$884.0K+20.6%
2017$733.0K+25.1%
2016$586.0K-49.6%
2015$1.16M+412.3%
2014$227.0K—